These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12480182)

  • 1. Synaptotagmin I and IV are differentially regulated in the brain by the recreational drug 3,4-methylenedioxymethamphetamine (MDMA).
    Peng W; Premkumar A; Mossner R; Fukuda M; Lesch KP; Simantov R
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):94-101. PubMed ID: 12480182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes.
    Peng W; Simantov R
    J Neurosci Res; 2003 Apr; 72(2):250-8. PubMed ID: 12672000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities.
    Boot BP; Mechan AO; McCann UD; Ricaurte GA
    Eur J Pharmacol; 2002 Oct; 453(2-3):239-44. PubMed ID: 12398910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission.
    Simantov R; Peng W
    FEBS Lett; 2004 Apr; 563(1-3):3-6. PubMed ID: 15063713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple molecular and neuropharmacological effects of MDMA (Ecstasy).
    Simantov R
    Life Sci; 2004 Jan; 74(7):803-14. PubMed ID: 14659969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.
    Wang X; Baumann MH; Xu H; Morales M; Rothman RB
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1002-12. PubMed ID: 15937150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive MDMA ('ecstasy') intake induces differential transcriptional changes in the mouse brain.
    Fernàndez-Castillo N; Orejarena MJ; Ribasés M; Blanco E; Casas M; Robledo P; Maldonado R; Cormand B
    Genes Brain Behav; 2012 Feb; 11(1):38-51. PubMed ID: 21951708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RETRACTED: Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").
    Ricaurte GA; Yuan J; Hatzidimitriou G; Cord BJ; McCann UD
    Science; 2002 Sep; 297(5590):2260-3. PubMed ID: 12351788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).
    Cole JC; Sumnall HR
    Neurosci Biobehav Rev; 2003 May; 27(3):199-217. PubMed ID: 12788333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B; Corradetti R
    Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.
    Saldaña SN; Barker EL
    Neurosci Lett; 2004 Jan; 354(3):209-12. PubMed ID: 14700733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
    Itzhak Y; Achat-Mendes CN; Ali SF; Anderson KL
    Neuropharmacology; 2004 Jan; 46(1):74-84. PubMed ID: 14654099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.
    Mouri A; Noda Y; Niwa M; Matsumoto Y; Mamiya T; Nitta A; Yamada K; Furukawa S; Iwamura T; Nabeshima T
    Behav Brain Res; 2017 Jun; 329():157-165. PubMed ID: 28472632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.
    Powell SB; Lehmann-Masten VD; Paulus MP; Gainetdinov RR; Caron MG; Geyer MA
    Psychopharmacology (Berl); 2004 May; 173(3-4):310-7. PubMed ID: 14747902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.